Detalhe da pesquisa
1.
BAP1 is a novel regulator of HIF-1α.
Proc Natl Acad Sci U S A
; 120(4): e2217840120, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36656861
2.
Trabectedin use in soft-tissue sarcoma patients in a real-world setting: Data from an Italian national drug-access registry.
Int J Cancer
; 152(4): 761-768, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36196483
3.
BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation.
Nature
; 546(7659): 549-553, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28614305
4.
Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour.
Br J Cancer
; 127(10): 1793-1798, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030294
5.
Ripretinib in advanced gastrointestinal stromal tumors: an overview of current evidence and drug approval.
Future Oncol
; 18(26): 2967-2978, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35880452
6.
KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and Treatment.
Chemotherapy
; 67(2): 81-90, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34983047
7.
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment.
Int J Mol Sci
; 23(5)2022 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35269621
8.
S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens.
Chemotherapy
; 66(5-6): 161-168, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644703
9.
Identification of Aneuploid Circulating Tumor Cells in Soft-Tissue Sarcoma Patients: A Pilot Study.
Oncology
; 98(12): 893-896, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32818940
10.
Secondary KIT mutations: the GIST of drug resistance and sensitivity.
Br J Cancer
; 120(6): 577-578, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30792534
11.
Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients.
Chemotherapy
; 64(2): 105-109, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390619
12.
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma.
Proc Natl Acad Sci U S A
; 113(47): 13432-13437, 2016 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27834213
13.
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin.
Oncology
; 95(1): 1-7, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29510410
14.
Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s.
PLoS Genet
; 11(12): e1005633, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26683624
15.
Immune checkpoint inhibition in sarcomas: time to be histology-specific?
Lancet Oncol
; 23(9): 1111-1112, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055298
16.
FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model.
J Transl Med
; 15(1): 58, 2017 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28298211
17.
Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity.
J Toxicol Environ Health B Crit Rev
; 19(5-6): 213-230, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27705545
18.
Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.
Carcinogenesis
; 36(1): 76-81, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25380601
19.
Evaluation of clonal origin of malignant mesothelioma.
J Transl Med
; 12: 301, 2014 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25471750
20.
Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling.
Am J Pathol
; 183(5): 1654-66, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24160326